Nurix Therapeutics Director Julia P. Gregory Reports Sale of Common Shares Worth $528,528.0154

Nurix Therapeutics director Julia P. Gregory sold 22,583 common shares at $23.4038 on Oct. 14, 2026, a Form 4 filing showed. Gregory exercised director stock options to acquire 22,583 common shares at $1.86 per share on the same date. Following the transactions, she directly owned 10,750 common shares, with none of the reported director stock options remaining. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001226675-26-000006), on October 14, 2026, and is solely responsible for the information contained therein. (C)